Mineralized poly(lactic acid) scaffolds loading vascular endothelial growth factor and the in vivo performance in rat subcutaneous model

Journal of Biomedical Materials Research - Part A

Volumn 101 A, Issue 5, 2013, Pages 1447-1455

  Kim, Joong Hyun ^a,b   Kim, Tae Hyun ^a,b   Jin, Guang Zhen ^a,b   Park, Jeong Hui ^a,b   Yun, Ye Rang ^a,b   Jang, Jun Hyeog ^c   Kim, Hae Won ^a,b,d  

^a BK21 Plus NBM Global Research Center for Regenerative Medicine   (South Korea)

^b Dankook University   (South Korea)

^c Inha University School of Medicine   (South Korea)

^d Dankook University   (South Korea)

Author keywords

CaP mineralization; PLA scaffold; rat subcutaneous model; surface modification; VEGF

Indexed keywords

BONE TISSUE ENGINEERING; CAP MINERALIZATION; IMMUNOHISTOCHEMICAL STAINING; THERAPEUTIC MOLECULES; TISSUE COMPATIBILITY; VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF; VON WILLEBRAND FACTOR;

BONE; CELL CULTURE; ENDOTHELIAL CELLS; LACTIC ACID; MINERALOGY; RATS; SCAFFOLDS (BIOLOGY); SURFACE TREATMENT; TISSUE;

LOADING;

CALCIUM PHOSPHATE; POLYLACTIC ACID; TISSUE SCAFFOLD; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MINERALIZATION; BONE TISSUE; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROBLAST; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; NONHUMAN; POROSITY; RAT; TISSUE ENGINEERING; VASCULARIZATION;

ANIMALS; CALCIUM PHOSPHATES; CELL PROLIFERATION; CELLS, CULTURED; COATED MATERIALS, BIOCOMPATIBLE; ENDOTHELIAL CELLS; HUMANS; LACTIC ACID; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; POLYMERS; POROSITY; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84875413901     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34446     Document Type: Article

References (46)

1. Leach JK, Kaigler D, Wang Z, Krebsbach PH, Mooney DJ,. Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. Biomaterials 2006; 27: 3249-3255.
2. Tuan RS, Boland G, Tuli R,. Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther 2003; 5: 32-45.
3. Murphy WL, Simmons CA, Kaigler D, Mooney DJ,. Bone regeneration via a mineral substrate and induced angiogenesis. J Dent Res 2004; 83: 204-210.
4. Levenberg S,. Engineering blood vessels from stem cells: recent advances and applications. Curr Opin Biotechnol 2005; 16: 516-523.
5. Kanczler JM, Barry J, Ginty P, Howdle SM, Shakesheff KM, Oreffo RO,. Supercritical carbon dioxide generated vascular endothelial growth factor encapsulated poly(DL -lactic acid) scaffolds induce angiogenesis in vitro. Biochem Biophys Res Commun 2007; 352: 135-141.
6. Lieberman JR, Daluiski A, Einhorn TA,. The role of growth factors in the repair of bone: biology and clinical applications. J Bone Joint Surg Am 2002; 84-A: 1032-1044.
7. Leach JK, Mooney DJ,. Bone engineering by controlled delivery of osteoinductive molecules and cells. Expert Opin Biol Ther 2004; 4: 1015-1027.
8. Hyon SH,. Biodegradable poly (lactic acid) microspheres for drug delivery systems. Yonsei Med J 2000; 41: 720-734.
9. Roorda WE, Bodde HE, De Boer AG, Junginger HE,. Synthetic hydrogels on drug-delivery system. Pharmacol Weekblad Sci Ed 1986; 8: 165-189.
10. Gomez C, Blanco MD, Bernardo MV, Sastre RL, Teijõn JM,. Poly (acrylamide-co-monoethyl itaconate) hydrogels as devices for cytarabine release in rats. J Pharm Pharmacol 1998; 50: 703-712.
11. Blanco MD, Bernardo MV, Gõmez C, Muñiz E, Teijõn JM,. Bupivacaine-loaded comatrix formed by albumin microspheres included in a poly(lactide-co-glycolide) film: in vivo biocompatibility and drug release studies. Biomaterials 1999; 20: 1919-1924.
12. Khan YM, Katti DS, Laurencin CT,. Novel polymer-synthesized ceramic composite-based system for bone repair: an in vitro evaluation. J Biomed Mater Res A 2004; 69: 728-737.
13. Wei G, Ma PX,. Structure and properties of nano-hydroxyapatite/polymer composite scaffolds for bone tissue engineering. Biomaterials 2004; 25: 4749-4757.
14. Bosetti M, Cannas M,. The effect of bioactive glasses on bone marrow stromal cells differentiation. Biomaterials 2005; 26: 3873-3879.
15. Hattar S, Asselin A, Greenspan D, Oboeuf M, Berdal A, Sautier JM,. Potential of biomimetic surfaces to promote in vitro osteoblast-like cell differentiation. Biomaterials 2005; 26: 839-848.
16. Ruhe PQ, Hedberg EL, Padron NT, Spauwen PH, Jansen JA, Mikos AG,. Biocompatibility and degradation of poly(DL -lactic-co-glycolic acid)/calcium phosphate cement composites. J Biomed Mater Res A 2005; 74: 533-544.
17. Klenke FM, Liu Y, Yuan H, Hunziker EB, Siebenrock KA, Hofstetter W,. Impact of pore size on the vascularization and osseointegration of ceramic bone substitutes in vivo. J Biomed Mater Res A 2008; 85: 777-786.
18. Ferrara N,. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004; 25: 581-611.
19. Richter GT, Fan CY, Ozgursoy O, McCoy J, Vural E,. Effect of vascular endothelial growth factor on skin graft survival in Sprague-Dawley rats. Arch Otolaryngol Head Neck Surg 2006; 132: 637-641.
20. Ferrara N,. Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol Immunol 1999; 237: 1-30.
21. Ennett AB, Kaigler D, Mooney DJ,. Temporally regulated delivery of VEGF in vitro and in vivo. J Biomed Mater Res A 2006; 79: 176-184.
22. Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, DiPietro LA,. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 1998; 152: 1445-1452.
23. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N,. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999; 5: 623-628.
24. Taub PJ, Silver L, Weinberg H,. Plastic surgical perspectives on vascular endothelial growth factor as gene therapy for angiogenesis. Plast Reconstr Surg 2000; 105: 1034-1042.
25. Howdieshell TR, Callaway D, Webb WL, Gaines MD, Procter CD Jr, Sathyanarayana, Pollock JS, Brock TL, McNeil PL,. Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation. J Surg Res 2001; 96: 173-182.
26. Mayr-Wohlfart U, Waltenberger J, Hausser H, Kessler S, Günther KP, Dehio C, Puhl W, Brenner RE,. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 2002; 30: 472-477.
27. Street J, Bao M, deGuzman L, Bunting S, Peale FV Jr, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RA, Filvaroff EH,. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 2002; 99: 9656-9661.
28. Murphy WL, Simmons CA, Kaigler D, Mooney DJ,. Bone regeneration via a mineral substrate and induced angiogenesis. J Dent Res 2004; 83: 204-210.
29. Silva EA, Mooney DJ,. Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis. J Thromb Haemost 2007; 5: 590-598.
30. Kim SH, Oh SA, Lee WK, Shin US, Kim HW,. Poly(lactic acid) porous scaffold with calcium phosphate mineralized surface and bone marrow mesenchymal stem cell growth and differentiation. Mater Sci Eng C 2010; 31: 612-619.
31. Dorj B, Kim MK, Won JE, Kim HW,. Functionalization of poly(caprolactone) scaffolds by the surface mineralization for use in bone regeneration. Mater Lett 2011; 65: 3559-3562.
32. Hoang QQ, Sicheri F, Howard AJ, Yang DS,. Bone recognition mechanism of porcine osteocalcin from crystal structure. Nature 425; 6961: 977-980.
33. Kempen DH, Lu L, Heijink A, Hefferan TE, Creemers LB, Maran A, Yaszemski MJ, Dhert WJ,. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 2009; 30: 2816-2825.
34. Hausman MR, Schaffler MB, Majeska RJ,. Prevention of fracture healing in rats by an inhibitor of angiogenesis. Bone 2001; 29: 560-564.
35. Yun YR, Jang JH, Jeon E, Kang W, Won JE, Kim HW, Wall I,. Administration of growth factors for bone regeneration. Regen Med 2012; 7: 369-385.
36. Sheridan MH, Shea LD, Peters MC, Mooney DJ,. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J Control Release 2000; 64: 91-102.
37. Yang F, Cho SW, Son SM, Bogatyrev SR, Singh D, Green JJ, Mei Y, Park S, Bhang SH, Kim BS, Langer R, Anderson DG,. Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles. Proc Natl Acad Sci USA 2010; 107: 3317-3322.
38. Yun YR, Won JE, Jeon E, Lee S, Kang W, Jo H, Jang JH, Shin US, Kim HW,. Fibroblast growth factors: biology, function, and application for tissue regeneration. J Tissue Eng 2010; 1: 218142.
39. Young SC, Bradica G, Hart CE, Karunanidhi A, Street RM, Schutte L, Hollinger JO,. Preclinical toxicology studies of recombinant human platelet-derived growth factor-BB either alone or in combination with beta-tricalcium phosphate and type I collagen. J Tissue Eng 2010; 1: 246215.
40. Post MJ, Laham R, Sellke FW, Simons M,. Therapeutic angiogenesis in cardiology using protein formulations. Cardiovasc Res 2001; 49: 522-531.
41. Lazarous DF, Shou M, Scheinowitz M, Hodge E, Thirumurti V, Kitsiou AN, Stiber JA, Lobo AD, Hunsberger S, Guetta E, Epstein SE, Unger EF,. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 1996; 94: 1074-1082.
42. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J,. Vascular-specific growth factors and blood vessel formation. Nature 2000; 407: 242-248.
43. Epstein SE, Fuchs S, Zhou YF, Baffour R, Kornowski R,. Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards. Cardiovasc Res 2001; 49: 532-542.
44. Kilpadi KL, Chang PL, Bellis SL,. Hydroxylapatite binds more serum proteins, purified integrins, and osteoblast precursor cells than titanium or steel. J Biomed Mater Res 2001; 57: 258-267.
45. Sawyer AA, Hennessy KM, Bellis SL,. The effect of adsorbed serum proteins, RGD and proteoglycan-binding peptides on the adhesion of mesenchymal stem cells to hydroxyapatite. Biomaterials 2007; 28: 383-392.
46. Wassell DT, Hall RC, Embery G,. Adsorption of bovine serum albumin onto hydroxyapatite. Biomaterials 1995; 16: 697-702.